COVID-19 vaccine: Moderna says preparing for launch; report shows 'strong immune response'
The COVID-19 vaccine was generally well-tolerated across all age groups and induced rapid and strong immune responses, a study shows
Dubbed as mRNA-1273, the vaccine has been developed by Moderna in partnership with the US government’s National Institutes of Health
Moderna Inc said on Thursday it was preparing to launch its experimental coronavirus vaccine. “We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world," Moderna CEO Stephane Bancel said in a press release. The company has received $1.1 billion in customer deposits for the shots during the third quarter, the company mentioned in the filing.